Literature DB >> 12730523

Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection.

M Ramos-Casals1, O Trejo, M García-Carrasco, J Font.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12730523     DOI: 10.1093/rheumatology/keg299

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  8 in total

1.  Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study.

Authors:  Judith Tsui; Eric Vittinghoff; Kathryn Anastos; Michael Augenbraun; Mary Young; Marek Nowicki; Mardge H Cohen; Marion G Peters; Elizabeth T Golub; Lynda Szczech
Journal:  Am J Kidney Dis       Date:  2009-04-25       Impact factor: 8.860

2.  A retrospective analysis of treatment outcomes in patients with hepatitis C related systemic vasculitis receiving intravenous methylprednisolone and cyclophosphamide.

Authors:  Amira A Shahin; Soha M El Desouky; Hania S Zayed
Journal:  Clin Rheumatol       Date:  2010-10-06       Impact factor: 3.650

3.  HCV Infection Alters Salivary Gland Histology and Saliva Composition.

Authors:  J O Maldonado; M E Beach; Y Wang; P Perez; H Yin; E Pelayo; S Fowler; I Alevizos; M Grisius; A N Baer; B Walitt; V De Giorgi; H J Alter; B M Warner; J A Chiorini
Journal:  J Dent Res       Date:  2022-01-20       Impact factor: 8.924

Review 4.  Xerostomia due to systemic disease: a review of 20 conditions and mechanisms.

Authors:  H Mortazavi; M Baharvand; A Movahhedian; M Mohammadi; A Khodadoustan
Journal:  Ann Med Health Sci Res       Date:  2014-07

Review 5.  Virus-mediated modulation of the host endocrine signaling systems: clinical implications.

Authors:  Tomoshige Kino; George P Chrousos
Journal:  Trends Endocrinol Metab       Date:  2007-04-02       Impact factor: 12.015

6.  DFV890: a new oral NLRP3 inhibitor-tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function.

Authors:  Ildiko Madurka; Alexander Vishnevsky; Joan B Soriano; Stephanus J Gans; Danilo Joel Salazar Ore; Adrian Rendon; Charlotte S Ulrik; Sushma Bhatnagar; Srikanth Krishnamurthy; Kirsten Mc Harry; Tobias Welte; Alberto A Fernandez; Beata Mehes; Karin Meiser; Ewa Gatlik; Ulrike Sommer; Guido Junge; Ederlon Rezende
Journal:  Infection       Date:  2022-09-14       Impact factor: 7.455

7.  Autoimmune thyroid disorders in hepatitis C virus infection: Effect of interferon therapy.

Authors:  Zohreh Jadali
Journal:  Indian J Endocrinol Metab       Date:  2013-01

Review 8.  Frequency of thyroid dysfunctions during interferon alpha treatment of single and combination therapy in hepatitis C virus-infected patients: a systematic review based analysis.

Authors:  Chandrasekharan Nair Kesavachandran; Frank Haamann; Albert Nienhaus
Journal:  PLoS One       Date:  2013-02-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.